Journal News

MCP: Proteogenomics researchers find causes of immune disease

Laurel Oldach
April 1, 2019

Routine clinical sequencing has given doctors unprecedented insight into genetic disorders. However, genomics fails to diagnose up to half of patients who are tested. That’s the problem that scientists at universities in Munich and Berlin tackled in a recent study in the journal Molecular & Cellular Proteomics. With samples from patients in four countries and a novel database on the neutrophil proteome, Christoph Klein and colleagues diagnosed two children with severe congenital neutropenia using mass spectrometry-based proteomics when typical sequencing had failed.

NeutrophilsNeutrophils, like the one in the center of this photo, are loaded with granules full of proteases that make them difficult to study. Guy Waterval /Wikimedia Commons

“There are very few examples of people who use multiple omics to investigate rare diseases … (but) I think this is the future of personalized medicine,” said Klein, a physician and director of the Children’s Hospital of the University of Munich.

The patients’ disease affects their neutrophils, white blood cells packed with toxic proteins to deploy against bacteria. When neutrophil development is disrupted, which Klein estimates happens to 1 in 200,000 newborns, every bacterial or fungal infection can become a life-threatening medical emergency.

Klein’s lab has studied rare genetic causes of neutropenia for years, but proteomics was a new field for the group. Postdoctoral researcher Sebastian Hesse met proteogenomics expert Juri Rappsilber at a conference, sparking a collaboration to study the proteome and transcriptome of neutrophil granulocytes.

Neutrophils are post-mitotic and very fragile, which makes studying them a challenge.

“You can think of them as suicide bombers,” Klein said, explaining that the cells are full of granules loaded with proteases that make retrieving other proteins a challenge. Hesse painstakingly developed a protocol to collect intact proteins and mRNA from healthy neutrophils.

Using mass spectrometry, scientists led by co-first author Piotr Grabowski in the Rappsilber lab at the Technical University of Berlin analyzed the cells’ proteome. When they added transcriptomic data, they found strikingly little correlation with the proteome, so they chose to focus on protein in patient samples.

Next, Hesse collected neutrophils from 16 patients with congenital neutropenia. Some were in Germany; to find others, he had to travel.

“These patients are from various parts of the world — that’s another unique challenge of working with rare diseases,” Klein said. “Sebastian flew to Iran and Turkey, in a collaborative effort with the pediatric hospitals there.”

Back at home, after processing and freezing the samples, Hesse handed them off to Grabowski; the proteomics scientists repeated the analyses to see what proteins had changed in the patients’ blood.

The team used abnormal protein profiles to guide the diagnosis of two patients with inconclusive exome sequencing results.

In one child’s case, a pseudogene made it difficult to identify mutations in the protein-coding gene; in the second, incomplete coverage by exome sequencing had missed a key point mutation. Data on protein abundance in each patient led the researchers to run more specific genetic tests that proved conclusive.

“This highlights (that) even if you have highly controlled pipelines for genetic studies, there’s always a risk that you are not 100 percent correct,” Klein said.

The researchers did not set out to make diagnoses from patient proteomes, but the study highlights the value proteomics data can add.

“Cellular proteome studies are not in routine clinical use at this point,” Klein said. “But … I think there will be huge potential for proteome analysis at a very low cost down the road.”

The team plans to expand its studies to other patients with immune deficiencies, looking for new genetic mechanisms of disease.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Related articles

From the journals: MCP
Nivedita Uday Hegdekar
From the journals: MCP
Nivedita Uday Hegdekar & Laurel Oldach
From the journals: MCP
Nuala Del Piccolo & Laurel Oldach

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Finding a third form of fat
Journal News

Finding a third form of fat

Oct. 26, 2021

When brown fat was discovered in human adults, it came as a surprise. A classic JBC study found another surprise: White fat cells could be coaxed into a phenotype resembling brown fat.

My cat’s coat is mostly white with dark tabby patches. What’s going on?
Science Communication

My cat’s coat is mostly white with dark tabby patches. What’s going on?

Oct. 24, 2021

A researcher uses a tweetorial to figure out the underlying genetics for their cat’s coat.

Dalit scientists face barriers in India’s top science institutes
Diversity

Dalit scientists face barriers in India’s top science institutes

Oct. 23, 2021

Despite decades-old inclusion policies, Dalits are systematically underrepresented in science institutes in India. Why?

‘It goes both ways’
Interview

‘It goes both ways’

Oct. 21, 2021

This year’s theme of “location, location, location” refers to the scenic meeting spot and to a new way of looking at lipids.

From the journals: JLR
Journal News

From the journals: JLR

Oct. 19, 2021

Predicting drug-induced lysosomal fat buildup. Minimizing side effects of atherosclerosis treatment. Finding a key to sepsis diagnosis and treatment. Read about papers on these topics recently published in the Journal of Lipid Research.

A new way of looking at concussions
News

A new way of looking at concussions

Oct. 17, 2021

Emerging research suggests that even mild hits to the head may damage the tiny lymphatic vessels that clear toxic chemicals and cellular debris from the brain.